Drug Eluting Stents Market

Drug Eluting Stents Market contains market size and forecasts of Drug Eluting Stents(DES) in global, including the following market information:
Global Drug Eluting Stents(DES) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Drug Eluting Stents(DES) Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Drug Eluting Stents(DES) companies in 2021 (%)
The global Drug Eluting Stents(DES) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cobalt-chromium Alloy Stents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Drug Eluting Stents(DES) include Abbott Vascular, Advantec Vascular, B.Braun Melsengen AG, Biosensors, Biotronik, Blue Medical, Boston Scientific, DISA Vascular and Essen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drug Eluting Stents(DES) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drug Eluting Stents(DES) Market, by Materials, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Drug Eluting Stents(DES) Market Segment Percentages, by Materials, 2021 (%)
Cobalt-chromium Alloy Stents
Magnesium Alloy Stents
Tyrosine Polycarbonate Stents
Nitinol Stents
Platinum Chromium Alloy Stents
Stainless Steel Stents
Other Materials
Global Drug Eluting Stents(DES) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Drug Eluting Stents(DES) Market Segment Percentages, by Application, 2021 (%)
Coronary Heart Disease
Clinical
Global Drug Eluting Stents(DES) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Drug Eluting Stents(DES) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drug Eluting Stents(DES) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Drug Eluting Stents(DES) revenues share in global market, 2021 (%)
Key companies Drug Eluting Stents(DES) sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Drug Eluting Stents(DES) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical